Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» psoriasis
psoriasis
Amgen ramps up Otezla expansion effort with positive data in mild psoriasis
Fierce Pharma
Thu, 05/7/20 - 12:27 am
Amgen
Celgene
Otezla
psoriasis
Lilly spends big on mirikizumab
EP Vantage
Thu, 02/13/20 - 10:40 am
Eli Lilly
mirikizumab
psoriasis
clinical trials
AbbVie Reports Successful Trial Results for Arthritis Drug
Motley Fool
Wed, 02/5/20 - 10:00 pm
AbbVie
Rinvoq
Upadacitinib
psoriasis
clinical trials
AbbVie and Boehringer Ingelheim's Skyrizi Beat Novartis' Cosentyx in Plaque Psoriasis
Motley Fool
Wed, 01/15/20 - 10:56 am
AbbVie
Boehringer Ingelheim
Skyrizi
Novartis
Cosentyx
psoriasis
Durect shares rocked by midstage psoriasis flop, shifts focus to liver disease
Fierce Biotech
Fri, 01/3/20 - 09:46 am
Durect
clinical trials
psoriasis
DUR-928
UCB posts more supportive data from Humira rival bimekizumab
Pharmaforum
Fri, 12/6/19 - 09:31 pm
UCB Pharma
bimekizumab
AbbVie
Humira
psoriasis
biosimilars
Amgen juices up sales outlook amid high hopes for Celgene castoff Otezla
Fierce Pharma
Thu, 11/21/19 - 06:29 pm
Amgen
Otezla
Celgene
psoriasis
UCB adds on more positive PhIII data for IL-17A/17F inhibitor bimekizumab, clearing a path to the FDA
Endpoints
Fri, 11/15/19 - 11:12 am
UCB Pharma
bimekizumab
psoriasis
clinical trials
Johnson & Johnson's Tremfya backs psoriatic arthritis play with newest data
Fierce Pharma
Tue, 11/12/19 - 10:03 am
JNJ
Tremfya
psoriatic arthritis
psoriasis
clinical trials
J&J’s Tremfya Shows Extended Success in Treating Plaque Psoriasis
BioSpace
Mon, 10/21/19 - 10:00 am
JNJ
Janssen
Tremfya
clinical trials
psoriasis
UCB's bispecific beats J&J's Stelara in psoriasis phase 3
Fierce Biotech
Fri, 10/18/19 - 07:47 pm
UCB Pharma
bispecific antibodies
bimekizumab
JNJ
Stelara
psoriasis
UCB tries to win some respect in the crowded psoriasis market with a dual IL-17 approach — and it won't be easy
Endpoints
Thu, 10/17/19 - 10:24 am
UCB Pharma
Amgen
psoriasis
bimekizumab
Sienna Biopharmaceuticals Files for Bankruptcy, Delaying Phase III Psoriasis Trial
BioSpace
Wed, 09/18/19 - 06:59 pm
Sienna Biopharmaceuticals
bankruptcy
psoriasis
SNA-120
Skyrizi looks ready to soar after strong launch
Biopharma Dive
Wed, 09/4/19 - 11:23 pm
AbbVie
Skyrizi
psoriasis
Celgene sells psoriasis pill to Amgen for $13.4 billion, clearing way for close of Bristol merger
Stat
Mon, 08/26/19 - 10:24 am
Amgen
Otezla
Celgene
M&A
Bristol-Myers Squibb
psoriasis
5 Biggest New Drugs Approved in 2019 So Far
Motley Fool
Tue, 08/13/19 - 11:43 am
drug approvals
FDA
AbbVie
JNJ
Novartis
Pfizer
Skyrizi
psoriasis
Vyndaqel
Zolgensma
SMA
Mayzent
multiple sclerosis
Balversa
metastatic bladder cancer
Eli Lilly's Taltz bests J&J rival Tremfya in head-to-head psoriasis tilt
Fierce Pharma
Tue, 08/13/19 - 11:40 am
Eli Lilly
Taltz
JNJ
Tremfya
psoriasis
AbbVie's psoriasis launch Skyrizi hitting stride ahead of FDA's decision on upadacitinib
Fierce Pharma
Fri, 07/26/19 - 12:07 pm
AbbVie
Humira
biosimilars
Europe
psoriasis
rheumatoid arthritis
Skyrizi
Eli Lilly's Taltz touts long-term clear skin data after unimpressive first-quarter sales
Fierce Pharma
Tue, 06/11/19 - 06:00 pm
Eli Lilly
Taltz
psoriasis
Ramaswamy's Dermavant Updates $124 Million IPO Filing
CP Wire
Mon, 06/10/19 - 09:53 am
Dermavant
IPOs
tapinarof
psoriasis
dermatitis
Vivek Ramaswamy
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »